Literature DB >> 6236747

Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.

H F Chambers, M A Sande.   

Abstract

In rabbits with experimentally induced endocarditis, the efficacy of teicoplanin compared favorably both with that of nafcillin for infection by a methicillin-susceptible strain of Staphylococcus aureus and with that of vancomycin for infection by a methicillin-resistant strain of S. aureus. In a 4-day treatment regimen, teicoplanin was as effective as either nafcillin or vancomycin in eliminating organisms from aortic valve vegetations in the respective infection. In a 10-day regimen for methicillin-resistant S. aureus endocarditis, both teicoplanin and vancomycin sterilized the vegetations of some rabbits, but the relapse rate was high for both. These results justify further investigation into the role of teicoplanin for the treatment of serious infections caused by S. aureus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236747      PMCID: PMC179917          DOI: 10.1128/AAC.26.1.61

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.

Authors:  M H Miller; M A Wexler; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.

Authors:  M A Sande; M L Johnson
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

3.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

Authors:  F Parenti; G Beretta; M Berti; V Arioli
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

4.  Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.

Authors:  J Carrizosa; W D Kobasa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

5.  Treatment of infections due to methicillin-resistant Staphylococcus aureus.

Authors:  C Watanakunakorn
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

6.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.

Authors:  M R Bardone; M Paternoster; C Coronelli
Journal:  J Antibiot (Tokyo)       Date:  1978-03       Impact factor: 2.649

7.  Comparative in vitro study of teichomycin A2.

Authors:  V Fainstein; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

8.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10

9.  Experimental endocarditis. 3. Natural history of catheter induced staphylococcal endocarditis following catheter removal.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
  9 in total
  26 in total

1.  Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.

Authors:  W E Peetermans; J J Hoogeterp; A M Hazekamp-van Dokkum; P van den Broek; H Mattie
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

Review 2.  Methicillin-resistant staphylococci: detection methods and treatment of infections.

Authors:  C J Hackbarth; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.

Authors:  N Galanakis; H Giamarellou; N Vlachogiannis; C Dendrinos; G K Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment.

Authors:  Y Domart; C Pierre; B Clair; J J Garaud; B Regnier; C Gibert
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

5.  The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.

Authors:  A Webster; A P Wilson; A H Williams; T Treasure; R N Grüneberg
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

6.  Serum bactericidal titer as a predictor of outcome in endocarditis.

Authors:  C J Hackbarth; H F Chambers; M A Sande
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

7.  Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

8.  Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia.

Authors:  C Y Liu; W S Lee; C P Fung; N C Cheng; C L Liu; S P Yang; S L Chen
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

9.  Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits.

Authors:  P Tattevin; A Saleh-Mghir; B Davido; I Ghout; L Massias; C Garcia de la Maria; J M Miró; C Perronne; F Laurent; A C Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

10.  Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.

Authors:  M W Climo; R L Patron; B P Goldstein; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.